External Company Press Release
A fascination with organic electronics
The three scientists succeeded in adapting organic semiconductors for use in a wide range of products, thereby creating the basis for innovative applications in displays, lighting, and photovoltaics.
External Company Press Release
Industrial Inkjet launched XYPrint 100 at Printed Electronics USA 2011
Industrial Inkjet Ltd (IIJ) exhibited at the 8th Annual IDTechEx Printed Electronics USA conference held in Santa Clara, CA November 30th through December 1st. IIJ presented the new XYPrint 100 deposition printer based on Konica Minolta printhead technology.
External Company Press Release
A3200 MotionPAC - integrated PLC and advanced motion
Aerotech's A3200 MotionPAC is a software-based Programmable Logic Controller (PLC) that is completely integrated with Aerotech's A3200 motion controller to increase programming efficiency, decrease development time and to increase quality.
External Company Press Release
Metalonix name change to Liquid X Printed Metals, Inc.
Metalonix, Inc., a ground-breaking provider of functional metallic inks, is pleased to announce its official corporate name has changed to Liquid X Printed Metals, Inc. ("Liquid X"). Liquid X spun out of Carnegie Mellon University in 2010 and is headquartered in Pittsburgh, Pennsylvania.
External Company Press Release
Flexible circuit technology, 4th edition now available
Technology never sleeps, and the five years that have passed since the previous edition of Flexible Circuit Technology was released have provided a substantial amount of new material for the all-new fourth edition of Flexible Circuit Technology, edited by 40-year electronics interconnection industry veteran Joseph Fjelstad and coauthored with some the world's top interconnection technologists.
External Company Press Release
RUSNANO helps an international player in innovative pharmaceuticals
RUSNANO has announced the acquisition of 41.37 percent of owners' equity in project company SynBio. RUSNANO paid 900 million rubles for the share as part of an earlier signed investment agreement whose participants include the Human Stem Cells Institute, Pharmsynthez, Cryonix, FDS Pharma LLP (United Kingdom), and Pharmsynthez's chairman Dmitry Genkin as a private investor .